What Is the Role of High-Dose Chemotherapy in the Era of Targeted Therapies?

This publication has 22 references indexed in Scilit:

• High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer
  New England Journal of Medicine, 2003
• Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
  The Lancet, 2000
• Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma
  JNCI: Journal of the National Cancer Institute, 2000
• Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement
  The Lancet, 1998
• Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
  Journal of Clinical Oncology, 1997
• Significance of Drug Dose, Timing and Radiotherapy in Adjuvant Therapy of Breast Cancer
  1984
• Autologous bone marrow transplantation in metastatic breast cancer
  Breast Cancer Research and Treatment, 1982
• Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
  New England Journal of Medicine, 1981
• High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors
  Cancer, 1980
• Treatment of disseminated cancer by intravenous hydroxyurea and autogenous bone-marrow transplants: Experience with 35 patients
  Journal of Surgical Oncology, 1975